Serial 97232172

Live / Registered — Registered (as of 20 Aug 2024)

What this means for you

Registered since 20 Aug 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97232172
Registration number
7482727
Mark type
Design / logo
Filed
21 Jan 2022
Published for opposition
06 Dec 2022
Registered
20 Aug 2024
Attorney of record
Timothy T. Wang

Goods and services

  • Class 005 — Pharmaceuticals: Vaccines; Anti-cancer preparations; Biological preparations for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Cytostatics for pharmaceutical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic reagents for medicinal use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of antibody-drug conjugate that facilitate the delivery of pharmaceutical preparations; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, elixirs for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Therapeutic pharmaceutical for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Tumor suppressing agents

Owner

Prosecution history

  • 20 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 20 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
  • 15 Jul 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 15 Jul 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 02 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 02 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 02 Jul 2024 — ASSIGNED TO LIE
  • 08 Jan 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 06 Nov 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
  • 06 Nov 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
  • 08 Aug 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 08 Aug 2023 — NON-FINAL ACTION E-MAILED
  • 08 Aug 2023 — SU - NON-FINAL ACTION - WRITTEN
  • 03 Aug 2023 — STATEMENT OF USE PROCESSING COMPLETE
  • 18 Jul 2023 — USE AMENDMENT FILED

View this trademark record on Marksy